癌症研究
癌症
医学
肝细胞癌
癌
肝细胞癌
肿瘤科
内科学
作者
Wenxin Xu,Jialei Weng,Yufei Zhao,Peiyi Xie,Minghao Xu,Shaoqing Liu,Qiang Yu,Mincheng Yu,Bugang Liang,Junbo Chen,Hui‐Chuan Sun,Hui Li,Qing‐Hai Ye,Ying-Hao Shen
标识
DOI：10.1136/jitc-2025-011648
摘要
We identified a novel FMO2+ CAF subset that serves as a critical regulator of microenvironmental immune properties and a predictive biomarker of the immunotherapy response in patients with HCC. CCL19 in combination with anti-PD-1 therapy may constitute a novel therapeutic strategy for HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
22336
Copyright
cdercder
Nole
OK
arniu2008
碧蓝破茧
水牛
xiaxiaxia
行走的荷尔蒙
pokexuejiao
ale
昏睡的蟠桃
sagitar
乐空思
愉快的真
yjh123
aaaa
卡乐瑞咩吹可
皖公网安备34019202002308
